Literature DB >> 26183879

K312 and E446 are involved in HCV RNA translation modulation by NS5A domains II and III.

Brett Hoffman1, Qing Shi2, Qiang Liu3.   

Abstract

HCV NS5A plays a critical role in the HCV life cycle. We previously demonstrated that NS5A down-regulates viral translation through a mechanism requiring the polyU/UC region of the viral 3'UTR and that each of the three domains is capable of carrying out this function individually. In this study, we mapped the regions and amino acid residues within domains II and III involved in the modulation of viral translation. Using a series of deletion and amino acid substitution mutants, we found that K312 and E446 play important roles in the modulation of viral translation by NS5A domains II and III, respectively. In the context of full-length NS5A, mutations of K312 and E446 alone or in combination again abrogate translation down-regulation. In a transient replication assay using HCV subgenomic replicons, the K312A mutation alone does not affect HCV replication throughout a 96-h time course. While the E446A mutation can increase HCV replication at early time points (4-24 h), the K312A and E446A double mutation can enhance viral replication at 24-96 h, suggesting both residues are involved. Our results shed more light on the functions of NS5A.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HCV NS5A domain II; HCV NS5A domain III; HCV RNA translation modulation; HCV replication; Hepatitis C virus (HCV)

Mesh:

Substances:

Year:  2015        PMID: 26183879     DOI: 10.1016/j.virusres.2015.07.007

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  1 in total

1.  The Hepatitis C virus NS5A and core proteins exert antagonistic effects on HAMP gene expression: the hidden interplay with the MTF-1/MRE pathway.

Authors:  Alexios Dimitriadis; Pelagia Foka; Eleni Kyratzopoulou; Eirini Karamichali; Stavroula Petroulia; Panagiota Tsitoura; Athanasios Kakkanas; Petros Eliadis; Urania Georgopoulou; Avgi Mamalaki
Journal:  FEBS Open Bio       Date:  2020-12-13       Impact factor: 2.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.